Ju Hee Oh

Ms. Ju Hee Oh

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
HSHyang Sook Seol
Hyang Sook Seol
JOJu Hee Oh
Ju Hee Oh
ECEunhye Choi
Eunhye Choi
SKSangMin Kim
SangMin Kim
HKHyunki Kim
Hyunki Kim
ENEun Ji Nam
Eun Ji Nam
Seol HS, et al. J Gynecol Oncol. 2022 Dec;34:e35. https://doi.org/10.3802/jgo.2023.34.e35

1 January 2019 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YCYeon Ji Chae
Yeon Ji Chae
DJDae Won Jun
Dae Won Jun
WSWaqar Khalid Saeed
Waqar Khalid Saeed
HKHyeon Tae Kang
Hyeon Tae Kang
JOJu Hee Oh
Ju Hee Oh
KJKiseok Jang
Kiseok Jang
Chae YJ, et al. J Korean Med Sci. 2018 Dec;34(2):e14. https://doi.org/10.3346/jkms.2019.34.e14

7 December 2011 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
PDF file
YSYong‐Jun Shin
Yong‐Jun Shin
JLJoo Hyun Lee
Joo Hyun Lee
JOJu Hee Oh
Ju Hee Oh
YLYoung‐Joo Lee
Young‐Joo Lee

9 October 2023 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
JOJu Hee Oh
Ju Hee Oh
WSWaqar Khalid Saeed
Waqar Khalid Saeed
HKHye Young Kim
Hye Young Kim
SLSeung Min Lee
Seung Min Lee
ALA Hyeon Lee
A Hyeon Lee
DJDae Won Jun
Dae Won Jun

22 March 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
ELEun Jeoung Lee
Eun Jeoung Lee
SLSeung Min Lee
Seung Min Lee
JOJu Hee Oh
Ju Hee Oh
HKHye Young Kim
Hye Young Kim
WSWaqar K. Saeed
Waqar K. Saeed
DJDae Won Jun
Dae Won Jun
Background: Previous studies have suggested that platelets are associated with inflammation and steatosis and may play an important role in liver health. Therefore, we evaluated whether antiplatelet agents can improve metabolic disorder-related fatty liver disease (MASLD). Methods: The mice used in the study were fed a high-fat-diet (HFD) and were stratified through liver biopsy at 18 weeks. A total of 22 mice with NAFLD activity scores (NAS) ≥ 4 were randomly divided into three groups (HFD-only, clopidogrel (CLO; 35 mg/kg/day), ticagrelor (TIC; 40 mg/kg/day) group). And then, they were fed a feed mixed with the respective drug for 15 weeks. Blood and tissue samples were collected and used in the study. Results: The TIC group showed a significantly lower degree of NAS and steatosis than the HFD group (p = 0.0047), but no effect on the CLO group was observed. Hepatic lipogenesis markers’ (SREBP1c, FAS, SCD1, and DGAT2) expression and endoplasmic reticulum (ER) stress markers (CHOP, Xbp1, and GRP78) only reduced significantly in the TIC treatment group. Inflammation genes (MCP1 and TNF-α) also decreased significantly in the TIC group, but not in the CLO group. Nile red staining intensity and hepatic lipogenesis markers were reduced significantly in HepG2 cells following TIC treatment. Conclusion: Ticagrelor attenuated NAS and hepatic steatosis in a MASLD mice model by attenuating lipogenesis and inflammation, but not in the CLO group.

25 October 2021 in The FASEB Journal
Verified
Journal Article
Closed access
PDF file
HKHye Young Kim
Hye Young Kim
SASang Bong Ahn
Sang Bong Ahn
JHJeong‐Min Hong
Jeong‐Min Hong
JOJu Hee Oh
Ju Hee Oh
WSWaqar Khalid Saeed
Waqar Khalid Saeed
DJDae Won Jun
Dae Won Jun